Literature DB >> 39297

Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine.

A J Carlson, W L Davidson, A A McLean, P P Vella, R E Weibel, A F Woodhour, M R Hilleman.   

Abstract

Mesh：

Substances：

Year:  1979        PMID： 39297     DOI： 10.3181/00379727-161-40596

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  12 in total

1.  Induction of anti-pneumococcal cell wall polysaccharide antibodies by type 4 pneumococcal polysaccharide-protein conjugates.

Authors:  C Peeters; A M Tenbergen-Meekes; J Poolmann; B Zegers; G Rijkers
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

2.  Simultaneous influenza and pneumococcal vaccination in elderly individuals.

Authors:  G Grilli; L Fuiano; L R Biasio; F Pregliasco; A Plebani; M Leibovitz; A G Ugazio; F Vacca; M L Profeta
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

3.  Safety of pneumococcal revaccination.

Authors:  R Rodriguez; P D Dyer
Journal:  J Gen Intern Med       Date:  1995-09       Impact factor: 5.128

4.  Vaccination against pneumococcal disease.

Authors:  H P Lambert
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

5.  Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults.

Authors:  M A Shelly; H Jacoby; G J Riley; B T Graves; M Pichichero; J J Treanor
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

6.  A strategy to improve the utilization of pneumococcal vaccine.

Authors:  C M Clancy; D Gelfman; R M Poses
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

7.  Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine.

Authors:  Ken B Waites; Kay C Canupp; Yu-Ying Chen; Michael J DeVivo; Moon H Nahm
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

8.  Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.

Authors:  J H Kehrl; A S Fauci
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 10.  Vaccines for preventing influenza in healthy adults.

Authors:  Vittorio Demicheli; Tom Jefferson; Eliana Ferroni; Alessandro Rivetti; Carlo Di Pietrantonj
Journal:  Cochrane Database Syst Rev       Date:  2018-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.